Causes & What We Know/August 25, 2026/2 min read

When Eye Injury and Type 1 Diabetes Complications Collide: A Rare Case Study

Doctors describe an unusual case where a rare inflammatory eye condition developed alongside diabetic eye damage, highlighting how different eye problems can interact and complicate treatment.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

Sympathetic ophthalmia is a rare inflammatory eye condition that usually follows eye trauma or surgery and can develop in the uninjured eye weeks later.
When this rare condition occurs alongside diabetic retinopathy, it can worsen vision damage and make treatment more complex.
Managing inflammation while protecting blood sugar control is a critical balancing act in these complicated cases.
Even when recovery is slow and requires multiple interventions, vision improvement is possible with coordinated care.

A Rare Double Challenge

A 27-year-old woman with Type 1 diabetes experienced an unusual medical situation: she developed a rare inflammatory eye condition called sympathetic ophthalmia in her uninjured eye, ten weeks after suffering a penetrating injury to her other eye. Sympathetic ophthalmia is uncommon—it is a two-eyed inflammatory condition that typically develops after eye trauma or surgery. The combination of this rare inflammation with diabetic retinopathy (diabetes-related damage to the blood vessels in the retina) made her case particularly challenging to diagnose and treat.

Why This Combination Is Complicated

In the affected eye, doctors observed multiple layers of damage: inflammation markers, swelling inside the eye, swelling of the optic nerve, and fluid buildup behind the retina—all occurring on top of existing proliferative diabetic retinopathy, a more advanced form of diabetic eye disease. Severe inflammation inside the eye can worsen diabetic retinopathy by increasing tissue damage and triggering new blood vessel growth, which is already a hallmark of the diabetes-related condition.

The challenge for her doctors was treating the inflammation while also managing her blood sugar, since some anti-inflammatory medications can raise glucose levels—a particular concern for someone with Type 1 diabetes.

The Treatment Approach

To control the inflammation, doctors started high-dose intravenous methylprednisolone (a corticosteroid) followed by an oral tapering dose. To reduce the risk that steroids would destabilize her blood sugar, they introduced adalimumab (a biologic immune-suppressing medication) early in treatment. Once the inflammation was controlled, doctors performed panretinal photocoagulation—a laser procedure used to treat advanced diabetic retinopathy.

Her vision improved significantly, from 20/100 to 20/25, and the fluid behind her retina largely resolved. However, the case became more complex when she became pregnant. During pregnancy, she developed bleeding inside the eye and scarring on the retina that eventually required surgical removal of vitreous fluid after delivery.

Long-Term Outcome and Lessons

By her final follow-up, her eye remained inflammation-free with a flat retina and vision of 20/40—meaningful improvement from where she started. This case illustrates an important medical principle: when rare inflammatory conditions occur alongside diabetic eye disease, recognizing both problems and controlling inflammation can help reduce further vision loss. It also shows that even in complicated situations, coordinated treatment across multiple eye problems can lead to measurable improvement, though recovery may require time and multiple interventions.

Evidence label

Source: BMC ophthalmology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.